In The News,

ADVI Welcomes New Vice President of Market Access

August 3, 2023, ADVI Health is excited to announce the appointment of Yana Volman as vice president of pharma in ADVI’s market access practice focused on market access. In this new role, Yana will work alongside ADVI’s internal experts and advisors to help biologics and drug manufacturers manage product lifecycles and effectively engage with organized decision makers.

Prior to joining ADVI, Yana served as lead of insights and innovation practice at COEUS, designed to inform strategic and tactical solutions for optimizing market access across various disease states. She has also held various leadership positions focused on content strategy and account management at Health Strategies Group (now EVERSANA), CommonHealth (now Ogilvy), and MediMedia Managed Markets (now ICON, plc).

“Yana’s previous experience makes her an excellent addition to our market access practice,” said Marc Samuels, CEO and president of ADVI. “Her deep understanding of not only what our clients need tactically and strategically but also understanding the needs of those they are trying to reach, whether that be patients, payers, or physicians, allows her to provide innovative solutions that help our clients meet their product-specific access, commercialization, data, and pricing goals.”

The 20-plus years of experience Yana brings to ADVI from across the healthcare landscape provides her with a unique perspective to see the bigger picture and provide valuable insights to clients. Bridging life sciences, research and development, and market research, she can advise and support clients with effective campaigns geared toward appropriate utilization management and patient access.

“I am incredibly excited to work alongside those at ADVI. I am looking forward to not only using my own experiences and expertise to help our clients, but I am excited about the opportunity to learn from our great policy experts to incorporate policy considerations into market access strategies and tactics for biologics and drug clients,” said Yana. “That is one of the reasons I chose to come to ADVI, the opportunity to bring new perspectives to our clients using all aspects of ADVI’s deep bench of expertise to develop innovative wraparound solutions and insights for their products, especially in our core areas of vaccines, cell and gene, rare disease, cancer, and other key therapeutic areas.”

Following the addition of Josh Greenblatt, Yana Volman’s onboarding to the market access solution area exemplifies ADVI’s commitment to expand and broaden its depth and breadth of experience to benefit its clients’ unique needs.